4SC & NKI Collaborate on Clinical Evaluation of Domatinostat in the Neoadjuvant Setting in Urothelial Cancer
4SC today announced the initiation of a second clinical collaboration with the Netherlands Cancer Institute (NKI) on a p…
4SC today announced the initiation of a second clinical collaboration with the Netherlands Cancer Institute (NKI) on a p…
4SC AG (4SC, FSE Prime Standard: VSC) today announced that a Trial in Progress poster entitled: 1153TiP - A phase II, op…
Die 4SC AG (4SC, FSE Prime Standard: VSC) gab heute bekannt, dass ein Trial in Progress-Poster mit dem Titel: 1153TiP -…